160 related articles for article (PubMed ID: 35633558)
1. Clinical Significance of TRIM44 Expression in Patients with Gastric Cancer.
Goshayeshi L; Afshar J; Mehrad-Majd H
Asian Pac J Cancer Prev; 2022 May; 23(5):1725-1731. PubMed ID: 35633558
[TBL] [Abstract][Full Text] [Related]
2. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer.
Afshar J; Mehrzad J; Mehrad-Majd H; Goshayeshi L; Saeidi J
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2445-2451. PubMed ID: 34452557
[TBL] [Abstract][Full Text] [Related]
4. Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis.
Xiao G; Yang Q; Bao Z; Mao H; Zhang Y; Lin S
BMC Cancer; 2020 Jun; 20(1):525. PubMed ID: 32503466
[TBL] [Abstract][Full Text] [Related]
5. Correlation between tripartite motif-containing protein 44 protein expression and the prognosis of postoperative patients exhibiting skin squamous cell carcinoma.
Wu J; Guo NZ; Cui LL; Wang W; Xiong CQ; Zhang XY
Medicine (Baltimore); 2018 Nov; 97(44):e13021. PubMed ID: 30383661
[TBL] [Abstract][Full Text] [Related]
6. TRIM58 suppresses the tumor growth in gastric cancer by inactivation of β-catenin signaling via ubiquitination.
Liu X; Long Z; Cai H; Yu S; Wu J
Cancer Biol Ther; 2020; 21(3):203-212. PubMed ID: 31747856
[No Abstract] [Full Text] [Related]
7. TRIM44 regulates tumor immunity in gastric cancer through LOXL2-dependent extracellular matrix remodeling.
Zhang X; Wu X; Sun Y; Chu Y; Liu F; Chen C
Cell Oncol (Dordr); 2023 Apr; 46(2):423-435. PubMed ID: 36512309
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
Liu WG; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7905-7912. PubMed ID: 31599413
[TBL] [Abstract][Full Text] [Related]
9. Combined A20 and tripartite motif-containing 44 as poor prognostic factors for breast cancer patients of the Japanese population.
Sato J; Azuma K; Kinowaki K; Ikeda K; Ogura T; Takazawa Y; Kawabata H; Kitagawa M; Inoue S
Pathol Int; 2021 Jan; 71(1):60-69. PubMed ID: 33159706
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of TRIM3 gene predicts a poor prognosis in gastric cancer.
Farhadi J; Goshayeshi L; Motavalizadehkakhky A; Mehrzad J; Mehrad-Majd H
J Gastrointest Cancer; 2022 Mar; 53(1):179-186. PubMed ID: 33415720
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
[TBL] [Abstract][Full Text] [Related]
12. Expression of TRIM44 and its correlation with TLR4 in laryngeal squamous cell carcinoma.
Bai J; Liu X; Zhang S; Dang S; Zhang Y; Zhang G
Cell Mol Biol (Noisy-le-grand); 2022 Jun; 68(6):56-61. PubMed ID: 36227676
[TBL] [Abstract][Full Text] [Related]
13. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of circRAD23B Exerts Antitumor Response in Colorectal Cancer via the Regulation of miR-1205/TRIM44 axis.
Han B; Wang X; Yin X
Dig Dis Sci; 2022 Feb; 67(2):504-515. PubMed ID: 33634427
[TBL] [Abstract][Full Text] [Related]
15. TRIM32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer.
Wang C; Xu J; Fu H; Zhang Y; Zhang X; Yang D; Zhu Z; Wei Z; Hu Z; Yan R; Cai Q
J Cell Mol Med; 2018 Oct; 22(10):5020-5028. PubMed ID: 30079558
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of TRIM44 is an independent marker for predicting poor prognosis in epithelial ovarian cancer.
Liu S; Yin H; Ji H; Zhu J; Ma R
Exp Ther Med; 2018 Oct; 16(4):3034-3040. PubMed ID: 30214522
[TBL] [Abstract][Full Text] [Related]
18. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
[TBL] [Abstract][Full Text] [Related]
19. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44.
Li W; Chen G; Feng Z; Zhu B; Zhou L; Zhang Y; Mai J; Jiang C; Zeng J
Genes Genomics; 2021 Dec; 43(12):1413-1421. PubMed ID: 34677810
[TBL] [Abstract][Full Text] [Related]
20. High TRIM44 expression in endometrial carcinoma is associated with a poorer patient outcome.
Li P; Yin H; Meng F; Liu S; Liu H; Ma R
Pathol Res Pract; 2018 May; 214(5):727-731. PubMed ID: 29526558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
